Related Experiment Videos
p53 mutations in matched primary and metastatic human tumors
S Peller1, A Halevy, S Slutzki
1Department of Hematology, Assaf Harofeh Medical Center, Zerifin, Israel.
Molecular Carcinogenesis
|July 1, 1995
Summary
Mutations in the p53 tumor suppressor gene are common in cancer. This study found p53 gene alterations in over half of patients, suggesting they play a role in tumor development and metastasis.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- The p53 tumor suppressor gene is frequently mutated in human cancers.
- Understanding the role of p53 mutations in cancer progression is crucial.
Purpose of the Study:
- To investigate the association between p53 gene mutations and neoplastic progression.
- To analyze p53 mutations in matched primary and metastatic tumor samples.
Main Methods:
- Analysis of matched primary and metastatic tumor samples (breast, gastrointestinal, colon, lung cancers).
- Polymerase chain reaction amplification and direct sequencing of p53 DNA or cDNA.
- Separation of DNA strands using magnetic streptavidin beads.
Main Results:
- p53 mutations were detected in 11 of 21 patients (52%).
- Shared mutations were observed in primary tumors and metastases in some patients.
- Unique mutations in primary tumors or metastases, or loss of heterozygosity, were also noted.
Conclusions:
- Tumor development and metastasis involve early structural alterations in the p53 gene.
- Genetic changes during metastasis can include new mutations or selection of cells with specific p53 mutations.